BridgeMD
New treatment option for Stable Neonates
Official title Phenylalanine, Methionine and Histidine Requirements in TPN Fed Neonates
ClinicalTrials.gov ID: NCT05562310
What this study is testing
What is Total parenteral nutrition (TPN). This is total nutrition provided by central vein.?
Total parenteral nutrition (TPN). This is total nutrition provided by central vein. is an investigational medicine, being studied as a potential treatment for stable neonates.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a single center project assessing the requirements for three essential amino acids in TPN fed neonates. Using the Carbon Oxidation method (indicator amino oxidation and direct amino acid oxidation method), the investigators will determine the requirement of each of the 3 amino acids.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 28
You may be able to join if
- Stable preterm babies that are growing and fully TPN fed (at least 90% of calories and protein).
- TPN providing adequate calories and protein as determined by attending physician and dietitian.
- Babies born ≥ 28 weeks gestation,
- ≤ 28 days chronological age at the time of the study,
- Birth weight and length appropriate for gestational age,
You likely can't join if
- Babies on mechanical ventilation, on low flow oxygen and CPAP.
- Small for gestational age,
- On medications known to affect protein and amino acid metabolism,
- Documented infection, fever
- Unstable medical condition
- Receiving enteral feeding providing \> 10% of protein intake.
See the full eligibility criteria
- Stable preterm babies that are growing and fully TPN fed (at least 90% of calories and protein).
- TPN providing adequate calories and protein as determined by attending physician and dietitian.
- Babies born ≥ 28 weeks gestation,
- ≤ 28 days chronological age at the time of the study,
- Birth weight and length appropriate for gestational age,
- Medically stable as determined by normal blood results and lack of a fever or infection,
- At least 3 days after surgery, if the baby had a surgery.
- Babies on mechanical ventilation, on low flow oxygen and CPAP.
- Small for gestational age,
- On medications known to affect protein and amino acid metabolism,
- Documented infection, fever
- Unstable medical condition
- Receiving enteral feeding providing \> 10% of protein intake.
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 day to 28 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.